Sunday
2:00 pm - 9:00 pm
Arrival and Check-in
6:00 pm - 7:00 pm
Dinner
7:30 pm - 7:40 pm
Introductory Comments by GRC Site Staff / Welcome from the GRC Chair
7:40 pm - 9:30 pm
Keynote Session: Breast Stem Cell Biology
Discussion Leader: Senthil Muthuswamy (Beth Israel Deaconess Medical Center and Harvard Medical School, United States)
7:40 pm - 7:55 pm
Introduction by Discussion Leader
7:55 pm - 8:55 pm
Joan Brugge (Harvard Medical School, United States)
"High Resolution Mapping of Breast Epithelial Cell Populations"
8:55 pm - 9:15 pm
Discussion
9:15 pm - 9:30 pm
General Discussion
Monday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Normal Breast Biology: Progenitor and Stem Cells
Discussion Leader: Renee Van Amerongen (University of Amsterdam, The Netherlands)
9:00 am - 9:10 am
Introduction by Discussion Leader
9:10 am - 9:35 am
Marja Mikkola (University of Helsinki, Finland)
"Building up the Mammary Gland: from Placode to First Branches"
9:35 am - 9:50 am
Discussion
9:50 am - 10:15 am
Elena Spina (Memorial Sloan Kettering Cancer Center, United States)
"Adhesion G Protein-Coupled Receptors in the Mammary Development and Breast Cancer"
10:15 am - 10:30 am
Discussion
10:30 am - 11:00 am
Coffee Break
11:00 am - 11:25 am
Weston Porter (Texas A&M University, United States)
"MAMsplaining: Mitophagy and Mitochondria-ER Interactions in Mammary Gland Development"
11:25 am - 11:40 am
Discussion
11:40 am - 11:55 am
Gat Rauner (Tufts University School of Medicine, United States)
"Combining 3D Organoids and Genetic Technologies to Reveal Developmental Programs"
11:55 am - 12:05 pm
Discussion
12:05 pm - 12:20 pm
Fabio De Martino (Swiss Institute for Experimental Cancer Research, Ecole Polytechnique Fédérale de Lausanne, Switzerland)
"Contraceptive Progestins Differ in Ability to Stimulate Proliferation of the Human Breast Epithelium"
12:20 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
3:00 pm - 4:00 pm
The GRC Power Hourâ„¢
The GRC Power Hourâ„¢ is designed to address diversity and inclusion in the scientific workplace by providing a safe environment for informal and meaningful conversations amongst colleagues of all career stages. The program supports the professional growth of all members of our communities, including ethnicity, race and/or gender identity by providing an open forum for discussion and mentoring.
Organizers: Leonie Young (Royal College of Surgeons in Ireland, Ireland) and Mohamed Bentires-Alj (University of Basel / University Hospital Basel, Switzerland)
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Abnormal Breast Biology: Precancerous Lesions (DCIS)
Discussion Leader: Fariba Behbod (University of Kansas Medical Center, United States)
6:00 pm - 6:10 pm
Introduction by Discussion Leader
6:10 pm - 6:35 pm
Janet Jones (Barts Cancer Institute, United Kingdom)
"Microenvironmental Influences on DCIS Behaviour"
6:35 pm - 6:50 pm
Discussion
6:50 pm - 7:15 pm
Jelle Wesseling (Netherlands Cancer Institute, The Netherlands)
"Preventing Unnecessary Breast Cancer Treatment"
7:15 pm - 7:30 pm
Discussion
7:30 pm - 7:45 pm
Adetunji Toriola (Washington University School of Medicine, United States)
"RANKL Inhibition and Breast Tissue Gene Expression in High-Risk Premenopausal Women with Dense Breasts: A phase I Pilot Clinical Trial"
7:45 pm - 7:55 pm
Discussion
7:55 pm - 8:00 pm
General Discussion
8:00 pm - 9:00 pm
Dinner
Tuesday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Group Photo
9:00 am - 12:30 pm
Heterogeneity in Breast Cancer
Discussion Leader: Walid Khaled (University of Cambridge, United Kingdom)
9:00 am - 9:10 am
Introduction by Discussion Leader
9:10 am - 9:35 am
Rama Khokha (Princess Margaret Cancer Centre, Canada)
"Multiomics Approach to Identifying Lineage Vulnerabilities and Druggable Targets"
9:35 am - 9:50 am
Discussion
9:50 am - 10:15 am
Sean Egan (Hospital for Sick Children, Canada)
"Modeling Breast Cancer Progression in Mice - From Sleeping Beauty to Chromosome Engineering"
10:15 am - 10:30 am
Discussion
10:30 am - 11:00 am
Coffee Break
11:00 am - 11:25 am
Helen Piwnica-Worms (The University of Texas MD Anderson Cancer Center, United States)
"Defining the Compositional, Spatial and Signaling Heterogeneity of Triple Negative Breast Cancer"
11:25 am - 11:40 am
Discussion
11:40 am - 11:55 am
Tarek Taifour (McGill University, Canada)
"Investigating the Role of the Secreted Cytokine Chitinase-3 Like Protein 1 in Immune Suppression and Breast Cancer Progression"
11:55 am - 12:05 pm
Discussion
12:05 pm - 12:20 pm
Nicolas Roth (Queen Mary University London, United Kingdom)
"Cannabinoid Receptor 2 Expression Leads to a Migratory Stem Cell Phenotype in HER2+ Breast Cancer"
12:20 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Molecular Alterations During Pregnancy and Lactation
Discussion Leader: Russell Hovey (University of California, Davis, United States)
6:00 pm - 6:10 pm
Introduction by Discussion Leader
6:10 pm - 6:35 pm
Camila dos Santos (Cold Spring Harbor Laboratory, United States)
"Life Modifiers of Pregnancy-Induced Mammary Gland Development"
6:35 pm - 6:50 pm
Discussion
6:50 pm - 7:15 pm
Carles Lerin (Institut de Recerca Sant Joan de Déu, Spain)
"Breast Milk Composition: Focus on One-Carbon Metabolism"
7:15 pm - 7:30 pm
Discussion
7:30 pm - 7:45 pm
Alejandro Collado (Spanish National Cancer Research Centre (CNIO), Madrid, Spain, Spain)
"Loss of Luminal Rank Signaling Leads to Basal Stem Cell Bipotency in Post Pregnancy Mammary Glands"
7:45 pm - 7:55 pm
Discussion
7:55 pm - 8:00 pm
General Discussion
8:00 pm - 9:00 pm
Dinner
Wednesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Residual Disease and Metastasis
Discussion Leader: Eva Gonzalez-Suarez (Centro Nacional de Investigaciones Oncológicas, Spain)
9:00 am - 9:10 am
Introduction by Discussion Leader
9:10 am - 9:35 am
Marianna Rapsomaniki (IBM Research, Switzerland)
"Artificial Intelligence and Single Cell Approaches to Unravel Tumor Heterogeneity"
9:35 am - 9:50 am
Discussion
9:50 am - 10:15 am
Brian Booth (Clemson University, United States)
"Investigating the Mechanisms of HER2+ Breast Cancer Cell Redirection"
10:15 am - 10:30 am
Discussion
10:30 am - 11:00 am
Coffee Break
11:00 am - 11:25 am
Mohamed Bentires-Alj (University of Basel / University Hospital Basel, Switzerland)
"To Sleep or Not to Sleep: Tumor Dormancy and Immune Host Defense"
11:25 am - 11:40 am
Discussion
11:40 am - 11:55 am
Hartland Jackson (Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Canada)
"Multiplex Imaging of Breast Cancer Lymph Node Metastases Identifies Prognostic Single-Cell Populations Independent of Clinical Classifiers"
11:55 am - 12:05 pm
Discussion
12:05 pm - 12:20 pm
Shayan Nazari (National Institutes of Health, United States)
"Long Prehensile Protrusions Pull Cells Through the Basement Membrane During Breast Cancer Invasion"
12:20 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Hormone Receptor Signaling
Discussion Leaders: Carrie Shemanko (University of Calgary, Canada)
6:00 pm - 6:10 pm
Introduction by Discussion Leader
6:10 pm - 6:35 pm
Cathrin Brisken (École Polytechnique Fédérale de Lausanne, Switzerland)
"Hormones in Control of ER+ Breast Cancer Development"
6:35 pm - 6:50 pm
Discussion
6:50 pm - 7:15 pm
Leonie Young (Royal College of Surgeons in Ireland, Ireland)
"Aberrant Epigenetic Events in ER+ Breast Cancer Metastasis: Releasing the Brake on Cancer Cell Plasticity"
7:15 pm - 7:30 pm
Discussion
7:30 pm - 7:45 pm
Bruno Simões (University of Manchester, United Kingdom, United Kingdom)
"Antagonizing Progesterone Signaling to Target Luminal Progenitor Cells and Prevent Breast Cancers"
7:45 pm - 7:55 pm
Discussion
7:55 pm - 8:00 pm
General Discussion
8:00 pm - 9:00 pm
Dinner
Thursday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Business Meeting
Nominations for the Next Vice Chair; Fill in Conference Evaluation Forms; Discuss Future Site and Scheduling Preferences; Election of the Next Vice Chair
9:00 am - 12:30 pm
Novel Approaches to Study Mammary Development and Disease
Discussion Leader: Gillian Farnie (University of Oxford, United Kingdom)
9:00 am - 9:10 am
Introduction by Discussion Leader
9:10 am - 9:35 am
Toni Celià-Terrassa (Hospital del Mar Medical Research Institute (IMIM), Spain)
"Stem Cell Implications in Breast Cancer Immunity"
9:35 am - 9:50 am
Discussion
9:50 am - 10:15 am
Joaquin Arribas ( Vall d'Hebron Institute of Oncology (VHIO), Spain)
"Safe Redirection of Cytotoxic Lymphocytes Against Breast Cancer Cells"
10:15 am - 10:30 am
Discussion
10:30 am - 11:00 am
Coffee Break
11:00 am - 11:25 am
Emilia Peuhu (University of Turku, Finland)
"Morphometric Analysis of Human Breast Tissue Using Light Sheet Microscopy"
11:25 am - 11:40 am
Discussion
11:40 am - 11:55 am
Nomeda Girnius (Harvard Medical School, United States)
"Understanding how Integrins and Extracellular Matrix Proteins Provide Resistance to Cilengitide in Breast Cancer"
11:55 am - 12:05 pm
Discussion
12:05 pm - 12:20 pm
Aditi Bapat (University of Minnesota, Minneapolis, MN, USA, United States)
"Contributions of NF-kB inTumor-Associated Macrophages Promoting Resistance to JAK Inhibition in Triple-Negative Breast Cancer"
12:20 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Keynote Session: Translational Breast Cancer Research
Discussion Leaders: Beatrice Howard (The Institute of Cancer Research, London, United Kingdom) and Maria Vivanco (CIC bioGUNE, Spain)
6:00 pm - 6:15 pm
Introduction by Discussion Leader
6:15 pm - 7:15 pm
Raoul Coombes (Imperial College, United Kingdom)
"Translational Aspects of Detection and Treatment of Endocrine Resistant Patients with Breast Cancer: New Approaches"
7:15 pm - 7:35 pm
Discussion
7:35 pm - 7:45 pm
General Discussion
7:45 pm - 8:00 pm
Closing Remarks
8:00 pm - 9:00 pm
Dinner
Friday
7:30 am - 8:30 am
Breakfast
9:00 am
Departure